229 related articles for article (PubMed ID: 11053056)
21. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
22. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
23. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
24. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
25. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
27. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
Silvers AL; Bachelor MA; Bowden GT
Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
[TBL] [Abstract][Full Text] [Related]
28. Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression.
Kawano H; Kim S; Ohta K; Nakao T; Miyazaki H; Nakatani T; Iwao H
J Am Soc Nephrol; 2003 Mar; 14(3):584-92. PubMed ID: 12595493
[TBL] [Abstract][Full Text] [Related]
29. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
30. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
31. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells.
Watabe M; Ito K; Masuda Y; Nakajo S; Nakaya K
Oncogene; 1998 Feb; 16(6):779-87. PubMed ID: 9488042
[TBL] [Abstract][Full Text] [Related]
32. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
33. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
34. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
35. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes.
Chen W; Bowden GT
Oncogene; 1999 Dec; 18(52):7469-76. PubMed ID: 10602506
[TBL] [Abstract][Full Text] [Related]
36. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A.
Lee JY; Park HR; Oh YK; Kim YJ; Youn J; Han JS; Kim JM
J Mol Med (Berl); 2007 Dec; 85(12):1393-404. PubMed ID: 17639289
[TBL] [Abstract][Full Text] [Related]
37. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.
Han Z; Boyle DL; Chang L; Bennett B; Karin M; Yang L; Manning AM; Firestein GS
J Clin Invest; 2001 Jul; 108(1):73-81. PubMed ID: 11435459
[TBL] [Abstract][Full Text] [Related]
38. The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages.
Ho FM; Lai CC; Huang LJ; Kuo TC; Chao CM; Lin WW
Br J Pharmacol; 2004 Mar; 141(6):1037-47. PubMed ID: 14980980
[TBL] [Abstract][Full Text] [Related]
39. Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells.
Lee HY; Chaudhary J; Walsh GL; Hong WK; Kurie JM
Oncogene; 1998 Jun; 16(23):3039-46. PubMed ID: 9662337
[TBL] [Abstract][Full Text] [Related]
40. IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases.
Rajnavolgyi E; Benbernou N; Rethi B; Reynolds D; Young HA; Magocsi M; Muegge K; Durum SK
Cell Signal; 2002 Sep; 14(9):761-9. PubMed ID: 12034357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
